Safe and efficacious use of recombinant human erythropoietin in malignancy
Drew Provan, Paul Greaves and Samir Agrawal
DOI: https://doi.org/10.7861/clinmedicine.7-6-617
Clin Med December 2007 Drew Provan
Institute of Cell and Molecular Science, The Royal London Hospital
Roles: Clinical Senior Lecturer in Haematology
Paul Greaves
Department of Haematological Oncology, St Bartholomew's Hospital (Queen Mary, University of London), London
Roles: Specialist Registrar in Haematology
Samir Agrawal
Department of Haematological Oncology, St Bartholomew's Hospital (Queen Mary, University of London), London
Roles: Senior Lecturer/Honorary Consultant

Article Information
vol. 7 no. 6 617-620
PubMed:
Published By:
Print ISSN:
Online ISSN:
Copyright & Usage:
© 2007 Royal College of Physicians
Other Contributors:
- Drew Provan [FRCP FRCPath], Clinical Senior Lecturer in Haematology, Institute of Cell and Molecular Science, The Royal London Hospital
Author Information
Article usage
Article Tools
Safe and efficacious use of recombinant human erythropoietin in malignancy
Paul Greaves, Samir Agrawal
Clinical Medicine Dec 2007, 7 (6) 617-620; DOI: 10.7861/clinmedicine.7-6-617
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.